Dr. Shoag and Dr. Spratt share advice on adding SpaceOAR to your practice
“Coordination between urology and radiation oncology, if urology is placing the device, is really critical,” says Jonathan E. Shoag, MD.
In this video, Jonathan E. Shoag, MD, and Daniel E. Spratt, MD, also discuss how the UH Seideman Cancer Center radiation oncology practice for prostate cancer has grown. Shoag is a urologist at University Hospitals and an assistant professor of urology at Case Western Reserve University School of Medicine, and Spratt is chair of Radiation Oncology at UH Cleveland Medical Center and a professor at Case Western Reserve University School of Medicine.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.
